One-year follow-up of a new posterior chamber toric phakic intraocular lens implantation for moderate-to-high myopic astigmatism
| Autor: | B. Tülü, Alper Agca, Mehmet Emin Sucu |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
genetic structures One year follow up business.industry medicine.medical_treatment Intraocular lens Spherical equivalent Astigmatism Phakic intraocular lens medicine.disease Refraction eye diseases Myopic astigmatism 03 medical and health sciences Ophthalmology 0302 clinical medicine 030221 ophthalmology & optometry medicine In patient business 030217 neurology & neurosurgery |
| Zdroj: | International Ophthalmology. 41:2941-2949 |
| ISSN: | 1573-2630 0165-5701 |
| DOI: | 10.1007/s10792-021-01853-7 |
| Popis: | To investigate refractive and visual outcomes as well as rotational stability following implantation of Eyecryl phakic toric intraocular lens (pIOL) for moderate-to-high myopic astigmatism. The efficacy, safety, predictability, stability, and adverse events of Eyecryl toric pIOL were evaluated in patients with spherical refraction from − 4.50 to − 18.50 diopters (D) and cylindrical refraction from − 0.50 to − 5.50 D. This study included 60 eyes of 31 patients. The mean manifest refraction spherical equivalent (MRSE) dropped from − 10.45 ± 2.74 D preoperatively to − 0.34 ± 0.51 D and − 0.40 ± 0.56 D at 6 and 12 months postoperatively, respectively. There was an 81% decrease in astigmatism after surgery. The safety and efficacy of indices were 1.36 ± 0.43 and 1.20 ± 0 .32. At the final follow-up, the rate of eyes within ± 1.00 D and ± 0.50 D of the desired MRSE were 85% and 68.33%, respectively. Vision-threatening complications were not observed during the follow-up. The implantation of pIOL was effective, safe, and predictable in patients with moderate-to-high myopic astigmatism during 1-year follow-up. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink